medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2011, Número 598

<< Anterior Siguiente >>

Rev Med Cos Cen 2011; 68 (598)


Cáncer de pene

Rivas SL

Idioma: Español
Referencias bibliográficas: 51
Paginas: 271-275
Archivo PDF: 288.42 Kb.


RESUMEN

El cáncer de pene se presenta principalmente en hombres mayores de 60 años, rara vez ocurre antes de los 40 años. Clínicamente la lesión más frecuente es una úlcera en el glande. Alrededor 58% de los pacientes inicialmente tienen adenopatías palpables. Se desconoce su causa exacta, pero se ha demostrado una relación directa con la infección por Virus de Papiloma Humano (VPH) de alto riesgo, especialmente del tipo 16. Otros factores de riesgo son la fimosis y la mala higiene. Por otro lado, la circuncisión neonatal se asocia con una disminución del riesgo. El diagnóstico se hace mediante el examen físico y la confirmación con biopsia. El tratamiento depende del sitio y de la extensión del tumor primario y de la presencia de metástasis inguinales.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Banon V, Nicolas N, Valdelvira P, et al. Penile verrucous carcinoma. Arch Esp Urol. 1999; 52; 937-940.

  2. Brinton LA, Li JY, Rong SD, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer 1991; 47:504–9.

  3. Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am1992; 19: 247–256.

  4. Caso J, Rodríguez A, Correa J, Spiess P. Update in the Management of penile cancer.International Braz J Urol. 2009;35:406-15.

  5. Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol 2003; 170: 359–365.

  6. Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005; 116:606–16.

  7. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135:180–189.

  8. Demuren OA, Koriech O. Isolated penile metastasis from bladder carcinoma. Eur Radiol 1999; 9: 1596–1598.

  9. Dodge OG, Linsell CA. Carcinoma of the penis in Uganda and Kenya africans. Cancer 1963; 16:1255–63.

  10. Di Capua Sacoto Carlos et al. Cáncer de pene. Nuestra experiencia en 15 años. Actas Urológicas Españolas. 2009; 33(2):143-148.

  11. Ferreira U, Ribeiro M, Reis L, Prudente A, Matheus W. Sentinel lymph node biopsy in penile cancer: a comparative study using modifi ed inguinal dissection. International Braz J Urol. 2008; 34:725-33.

  12. Fraley EE, Zhang G, Manivel C, Niehans GA. The role of ilioinguinal lymphadenectomy and signifi cance of histological differentiation in treatment of carcinoma of the penis. J Urol1989; 142: 1478–1482.

  13. Frisch M, Smith E, Grulich A, Johansen C. Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol 2003; 157:966–72.

  14. Fu-Fu Zheng, Yeu-You Liang, Yong-Shun Guo, Yu-Ping Dai, Ke-Li Zheng. Diagnosis and therapy for penile cancer. Chinese Journal of Cancer.27:9,248-251.

  15. Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol 1995; 75: 375–7.

  16. Hellberg D, Valentin J, Eklund T, Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behaviour? Br Med J (Clin Res Ed) 1987; 295:1306–8.

  17. Horenblas S, Tinteren H. Squamous cell carcinoma of the penis. Prognostic factors of survival: analysis of tumor, nodes and metastatsis classifi cation system. J Urol. 1994; 151: 1239.

  18. Horenblas S, Tinteren H, Delemarre J, Moonen L, Lustig V, Van Waardenburg E: Squamous cell carcinoma of the penis III. Treatment of regional lymp nodes. J Urol. 1993; 149: 492-497.

  19. Licklider S. Jewish penile carcinoma. J Urol 1961; 86: 98.

  20. Longombe AO, Lusi KM. Penile cancer in rural Zaire. Trop Geogr Med 1994; 46:366–7.

  21. Lucia MS, Miller GJ. Histopathology of malignant lesions of the penis. Urol Clin North Am1992; 19: 227–246.

  22. Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85:19–24.

  23. Madsen BS, van den Brule AJ, Jensen HL, Wohlfahrt J, Frisch M. Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17 (10): 2683-91.

  24. Maiche AG. Epidemiological aspects of cancer of the penis in Finland. Eur J Cancer Prev 1992; 1:153–8.

  25. Micali G, Innocenzi D, Nasca MR, Musumeci ML, Ferrau F, Greco M. Squamous cell carcinoma of the penis. J Am Acad Dermatol 1996; 35:432–51.

  26. Micali G, Nasca MR, Innocenzi D, Schwartz RA. Invasive penile carcinoma: a review. Dermatol Surg 2004; 30: 311–320.

  27. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004; 5:240–7.

  28. Mosconi AM, Roila F, Gatta G, Theodore C. Cancer of the penis. Crit Rev Oncol Hematol 2005; 53:165–77.

  29. Muro I, Azpiazu P, Recarte J, Ianki H, Manrique E. Metastatic carcinoma of penis: clinical assessment, treatment and review of literature. Arch Esp Urol.1999; 52: 994-998.

  30. Novara G, Galfano A, De M V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol 2007; 4:140–6.

  31. Ornellas AA, Seixas AL, Marota A, Wisnescky A, Campos F, de Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994; 151:1244-1249.

  32. Pascual A, Pariente M, Godinez JM, et al. High prevalence of human papillomavirus 16 in penile carcinoma. Histol Histopathol. 2007; 22: 177–83.

  33. Pow-Sang MR, Benavente V, Pow-Sang JE, et al. Cancer of the penis. Cancer Control. 2002; 9: 305–314.

  34. Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V. Epidemiology and natural history of penile cancer. Urology. 2010 Aug; 76 (2 Suppl 1): S2-6.

  35. Rando A, Pérz-Utrilla M, Aguilera A, Tabernero A, Cisneros J, De la Peña J. A review of penile cancer. Adv Urol. 2009; 2009:415062.

  36. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993; 72: 817-819.

  37. Slaton JW, Morgenstern N, Levy DA et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymp node metastasis in penile squamous cancer. J Urol. 2001; 165:1138-1142.

  38. Schellhammer P, Jordan G, Scholossberg S. Tumors of the penis, Campbell´s Urology, Ed Walsh, Retik, Stamey, Vaughan, WB Saunders company. 1992; 1264.

  39. Schoen EJ, Oehrli M, Colby C, Machin G. The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 2000; 105: E36.

  40. Singh AK, Saokar A, Hahn PF, Harisinghani MG. Imaging of penile neoplasms. Radiographics. 2005 Nov-Dec; 25(6):1629-38.

  41. Solsona N. Cáncer de pene. Actas Urológicas Españolas. 2002. 26 (8): 525-531.

  42. Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahl T. Europpean Association of Urology. EAU guidelines on penile cancer. Eur Urol. 2004; 46(1):1-8.

  43. Soria JC, Fizazi K, Piron D, et al. Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 1997; 8:1089–98.

  44. Soto Delgado M, Arredondo Martínez F, Pedrero Márquez G, Basquero González B, Zurera Cosano A, Linares Armada R. Cáncer de pene. Una revisión de 18 casos. Actas Urológicas Españolas.2003; 27(10):797-802.

  45. Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr. Penile cancer: relation of extent of nodal metastasis to survival. J Urol1987; 137: 880–882.

  46. Sufrin G, Huben R. Benign and malignant lesions of the penis. In: adult and pediatric urology. 2nd ed. Gillenwater JY(ed). Year Book Medical Published, Chicago. 1991; 1.643.

  47. Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 2001; 12: 267–77.

  48. Vapnek JM, Hricak H, Carroll PR. Recent advances in imaging studies for staging of penile and urethral carcinoma. Urol Clin North Am1992; 19: 257–266.

  49. Velazquez EF, Ayala G, Liu H, Chaux A, Zanotti M, Torres J et al. Histologic grade and perineural invasión are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol. 2008; 32(7):974-979.

  50. Vossough A, Pretorius ES, Siegelman ES, Ramchandani P, Banner MP. Magnetic resonance imaging of the penis. Abdom Imaging2002; 27: 640–659.

  51. Wideroff L, Schottenfield D. Penile Cancer. In: Schottenfeld D, Fraumeni JF. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006. p. 1166–72.




2020     |     www.medigraphic.com